Treating diabetes mellitus in Prader–Willi syndrome with Exenatide

Abstract We report the use of Exenatide, a GLP-1 agonist, in the management of diabetes mellitus in a 19 year-old female with Prader–Willi syndrome. The beneficial effects of Exenatide in weight reduction and appetite suppression provide a promising strategy for the treatment of obesity and diabetes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2011-04, Vol.92 (1), p.e1-e2
Hauptverfasser:	Seetho, Ian W, Jones, Gavin, Thomson, George A, Fernando, Devaka J.S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Diabetes mellitus Diabetes Mellitus - drug therapy Endocrinology & Metabolism Exenatide Female Ghrelin Ghrelin - therapeutic use Humans Obesity Peptides - therapeutic use Prader-Willi Syndrome - drug therapy Prader–Willi syndrome Venoms - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract We report the use of Exenatide, a GLP-1 agonist, in the management of diabetes mellitus in a 19 year-old female with Prader–Willi syndrome. The beneficial effects of Exenatide in weight reduction and appetite suppression provide a promising strategy for the treatment of obesity and diabetes mellitus in Prader–Willi syndrome.
ISSN:	0168-8227 1872-8227
DOI:	10.1016/j.diabres.2010.12.009